Twist Bioscience: Path To Profitability Beginning To Take Shape

Twist Bioscience (NASDAQ: TWST ) reported strong results again in the fourth quarter, with robust growth across each of its segments. Perhaps more importantly, the company's margins continue to improve, and management commentary suggests significant gains in FY25. This is particularly impressive givenRichard Durant is the leader of Narweena, an asset manager focused on finding market dislocations that are the result of a poor understanding of a businesses long-term prospects. Narweena believes that excess r ...